Skip to content

Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes

Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04552834
Enrollment
500
Registered
2020-09-17
Start date
2020-09-15
Completion date
2027-11-01
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Microbiome

Keywords

short term outcomes, long term outcomes

Brief summary

This study is designed to study the variations in the microbiome among critically ill patients and the effect of admission to the medical intensive care unit (MICU) at the University of Chicago. Additionally, investigators will examine the downstream clinical effects of dysbiosis in ICU patients and how patients maybe effected long term.

Detailed description

During this study investigators will longitudinally collect discarded stool biosamples throughout the MICU admission when available. Stool Bio specimens will be recorded/coded and processed by the investigators. Stool Bio specimens will be analyzed for 16sRNA and metabolomics. Surveys will be conducted at study entry, in addition to 6 months and 12 months following discharge. By longitudinally sampling discarded biospecimens from subjects throughout their MICU admission in additionally to describing long term following up. We will be able to correlate changes in the microbiome with clinical data, and follow up surveys to identify factors that may impact the composition of the microbiome and their impact on clinical outcomes.

Interventions

None listed

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

adult patients admitted to the intensive care unit

Exclusion criteria

none

Design outcomes

Primary

MeasureTime frameDescription
Long Term Mortalityup to 1 yearDeath from any cause 90 day, 1 year

Secondary

MeasureTime frameDescription
hospital mortality28 daydeath from any cause during hospitalization
ICU length of stayhospitalization up to 6 weeksnumber of days admitted to the ICU
Hospital length of stayhospitalization up to 6 weeksnumber of days admitted to the hospital
Functional Status Scoreup to 12 months after dischargeKatz Index of Independence in activities of daily living; minimal score = 0; maximum score = 6; higher score better outcome
Cognitive DysfunctionUp to 12 months after dischargeMontreal Cognitive Assessment (MoCA) score; minimal score = 0; maximum score = 30; higher score better outcome
Quality of Life scoreup to 12 months after dischargeSF-36 score: including physical component summary (PCS) and mental component summary (MCS)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBhakti Patel

University of Chicago

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 14, 2026